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Abstract  
 
Recently, findings of mismatch repair (MMR) proteins in mitochondria, which are usually regarded as being involved 
in MMR of chromosomal DNA, have given rise to speculation as to whether mitochondria contain an active MMR 
system. The proximity of mitochondrial DNA to damaging effects caused by oxygen gave rise to investigations of DNA 
repair systems working in mitochondria. Several mitochondrial repair mechanisms, such as base excision repair have 
been identified, whereas the existence of a mitochondrial mismatch repair system is not proven to exist. The present 
study is aimed to investigate whether occurrence of certain MMR proteins in mitochondria could be connected to other 
functions than a proper MMR system. A function in apoptosis was taken into account and assumed for hMLH1, since it 
is known to be a specific substrate of caspase-3, which plays an important role in apoptosis. The present study reveals 
that MMR proteins hMLH1 and PCNA are present in 293Tet off mitochondrial extracts. 
In addition it was attempted to investigate whether the MMR proteins Msh2 and Mlh1 are implicated in the repair of 
oxidative damage in the mitochondria of the budding yeast Saccharomyces cerevisiae. Conduction of an erythromycin 
assay showed no obvious involvement of Msh2 or Msh1 in the correction of oxidative damage. However more data is 
needed to conclude that this is really the case. Furthermore our findings indicate that a classical MMR system does not 
seem to exist in mitochondria, as the main complex MutSα could not be found. 
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List of abbreviations: 
 
ApaF-1:  Apoptotic Protease Activating Factor 1 
BER:  Base Excision Repair 
Caspase:  Cystine Aspartate  Specific Protease 
DD:  Dead domain motif 
DISC:  Death Inducing Signaling Complex  
FADD:  Fas Associated Death Domain 
MGMT:   O6-methylguanine-DNA methyltransferase 
MLS:  Mitochondrial Localization Sequence 
MMR:  Mismatch Repair 
MNNG:  N-Methyl-N-Nitro-N-Nitrosoguanidine 
MNU:  N-Methyl-N-nitrosourea 
mtDNA:  Mitochondrial DNA 
MTS:  Mitochondrial Targeting Sequence 
nDNA:  Nucleus DNA  
NER:  Nucleotide Excision Repair  
NLS:  Nuclear Localization Signal 
OGG1:  8-Oxo-G-Glycosylase 
PCNA:  Proliferating Cell Nuclear Antigen 
ROS:  Reactive Oxygen Species 
SSB:  Single Stranded DNA Binding Protein 
TNF:  Tumor Nerosis Factors  
TRAIL:  Tumor Necrosis Related Apoptosis Inducing Ligand 
TRE:  Tetracycline Response Element 
tTA:  Tetracycline-controlled Transactivator 
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1 Introduction 
 
Mitochondria are cell organelles present in the cytosol of eukaryotic cells. In animal cells, mitochondria are the only 
organelles outside the nucleus possessing DNA (Banerjee and Ghosh, 2004b). Depending on the cell type, over a 
thousand mitochondria may be present in a cell (Cotter et al., 2004). Mitochondria consist of two membranes, the outer 
and inner membrane, with the inner membrane enclosing the matrix where, in human cells, approximately 10-15 copies 
of the circular chromosome may reside, each consisting of 16569 base pairs (Lee and Wei, 2005; Van Houten et al., 
2005). The mtDNA (mtDNA) encodes 13 mRNAs, 22 tRNAs and 2 rRNAs. All 13 proteins, resulting from translation 
of the mRNA, are key components of the respiratory chain (Van Houten et al., 2005). This makes preservation of the 
mitochondrial genome critical for the cells ability to carry out oxidative phosphorylation which takes place at the inner 
membrane, where energy is converted from the electron transport chain to a proton gradient, which drives the synthesis 
of ATP (Van Houten et al., 2005).   
 
It has long been known that mtDNA is more prone to mutational events than nDNA (Singh et al., 2001). For yet 
unknown reasons, mutations in mtDNA, to the point of mitochondrial dysfunction, are a common characteristic among 
many cancer types (Modica-Napolitano and Singh, 2004). For many years the instability of mtDNA was generally 
thought of as a result of mitochondria being completely devoid of any DNA repair capacity. The presence of repair 
mechanisms was thought unlikely, partly because mitochondria contain multiple copies of DNA. Several copies of 
DNA give the cells the possibility of degrading damaged molecules or sort out damaged molecules during cell division. 
Additionally, nucleotide excision repair (NER) was found to be absent in mitochondria; in the nucleus NER is 
responsible for the removal of intrastrand crosslinks. Such lesions, induced by UV light and the chemotherapeutic agent 
cisplatin, showed no signs of being repaired in mtDNA (Clayton et al, 1975).  
It is commonly accepted today that mtDNA is protected by various repair systems. So far direct repair, base excision 
repair (BER) and recombination repair have been identified in the mitochondria of higher eukaryotes (Croteau et al., 
1999). All the proteins involved in these repair systems are encoded in the nucleus and translated in the cytosol from 
where they subsequently are transported into the mitochondria often directed by a mitochondrial targeting sequence 
(MTS), although this is not always the case (Singh et al., 2001; Van Houten et al., 2005). A common feature of the 
repair systems found in mitochondria is their simplicity; each involving only few proteins. Whether mitochondria 
harbour a DNA mismatch repair (MMR) system has not yet been established. Several studies, however, indicate that 
some kind of MMR-activity is present in mitochondria (reviewed in Larsen et al. 2005).  
 
Mitochondrial proteome analysis in the yeast Saccharomyces cerevisiae (S. cereviciae) has revealed the presence of the 
MMR proteins Mlh1 and Msh1 (Sickmann et al., 2003)  for a description of MMR see section 2.1. This is in 
accordance with the fact that Msh1, through studies using a vector expressing epitope tagged-Msh1 and subsequent 
immunofluorescence microscopy, has been shown to localize to mitochondria and bind base mismatches in the presence 
of ATP (Chi and Kolodner, 1994; Reenan and Kolodner, 1992). Furthermore, it has been found that mutations in Msh1 
result in the loss of mitochondrial function within 20 generations (Reenan and Kolodner, 1992). In addition it has been 
reported that diploid Msh1+/- strains exhibit an increased GT repeat instability suggesting that Msh1 stabilizes repetitive 
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GT sequences, called microsatellites, in mtDNA (Sia et al., 2000). Thus Msh1 seems to have an important role in the 
avoidance of mutations in the mitochondrial genome of yeast. A human homolog to the Msh1 protein has not yet been 
found. MMR like activity in human mitochondria has however been reported in several studies (Chen et al., 2001; 
Mason et al., 2003; Mason & Lightowlers, 2003).  
 
Figure 1: Summary of the Western blots conducted by Houg et al. (2004) using nuclear and mitochondrial extracts originating from the 
human cell lines SW480, LoVo, HCT116,  HCT116 + chr. 3 and HeLa. N: nuclear extract, M: mitochondrial extract. MMR+: MMR 
proficient, hMSH2-/- : hMSH2 deficient,  hMLH1-/- : hMLH1 deficient, MMR+/- MMR proficient, due to insert of functional chromosome. 
 
Recently the presence of MMR proteins in human mitochondria was examined by Houg et al. (2004), who carried out 
Western Blot analysis using mitochondrial extracts purified by Tinna Stevnsner and Morten Riser Nielsen, Aarhus 
University, Denmark. The mitochondrial extracts were originating from the MMR proficient human cell lines SW480, 
HeLa and HCT116 + chr. 3, and the hMLH1 and hMSH2 deficient cell lines HCT116 and LoVo, respectively - for a 
description of the used cell lines see section 3.1. Full length hMLH1 was detected in the mitochondrial extracts of all 
cell cultures except HeLa and the hMLH1 deficient HCT116. As hMLH1 is a protein normally associated with nuclear 
MMR this raises the question of what function this protein serves in the mitochondria, if any. The nuclear extracts 
corresponding to the mitochondrial extracts showing large amounts of hMLH1 surprisingly showed what seems to be a 
processing of hMLH1. In fig. 1 three distinct bands of hMLH1 can be seen in the nuclear extracts of all the hMLH1 
proficient cell lines (SW480, LoVo and HCT116 + chr. 3) except for HeLa.  
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hPMS2 was detected in very small amounts in the mitochondrial extracts of SW480 and LoVo. Whether this small 
amount is due to nuclear contamination is not clear since the hMLH1 proficient HCT116 + chr. 3 clearly do not contain 
any hPMS2 in the mitochondrial extract. Nuclear degradation of hPMS2 seems to correlate with nuclear cleavage of its 
partner hMLH1, which is expected since hPMS2 is unstable without its partner (Yao et al., 1999). 
hMSH2 was detected in SW480 cells, however the presence of hMSH2 could be due to contamination with nuclear 
genomic DNA. The SW480 mitochondrial extract seemed sticky and dense at the time of loading, indicating a 
contamination with genomic DNA and possibly associated DNA binding proteins (Rasmussen, pers. comm.).  
No hMSH6 was detected in mitochondrial extracts of any of the cell lines. The band present in the mitochondrial extract 
of SW480 does not have the right size. It could be some kind of degradation product or just an unspecific binding of the 
hMSH6 antibody. Mitochondrial extracts from all cell lines except HCT116 and HCT116 + chr. 3 surprisingly show 
large amounts of human proliferating cell nuclear antigene (hPCNA), which has previously been demonstrated in 
animal mitochondria. In the nucleus PCNA normally functions as a processivity factor for the nuclear polymerases, also 
during polymerase δ´s resynthesis of the excised mismatch in MMR (Li, 2003). Whether PCNA acts as a processivity 
factor for the only DNA polymerase operating in mitochondria, polymerase γ (Hübscher et al., 2002), has not yet been 
settled, see section 2.1. Thus, if an MMR activity is present in mitochondria it must function without hMSH6, 
presumably without hMSH2 and perhaps without hPMS2. Absence of hMSH2 and hMSH6 in mitochondria makes the 
existence of classical MMR known from the nucleus unlikely 
COXII is normally only found inside the mitochondria and is used as a control in these experiments. If COXII appears 
in nuclear extracts these might be cross contaminated. 
Recently, Chen et al. (2004) showed that hMLH1 is cleaved by caspase-3 in cancer cells, after induction of apoptosis 
by tumour necrosis related apoptosis inducing ligand (TRAIL) and etoposide. When the caspase- 3 cleavage signal in 
hMLH1 was mutated the cells became resistant to treatment with etoposide while treatment with TRAIL did not have 
the same resistance effect. The hMLH1 bands in the Western Blot conducted by Houg et al. (2004) have shown to be 
similar in size (45- and 40 kDa) to the caspase- 3 cleaved products described by Chen et al. (2004). In contrast, no 
obvious caspase- 3 cleavage signals have been found in hPMS2. The fact that hMLH1 seems to have been cleaved by 
caspase- 3 indicate that some of the cell cultures used in this study at the time of harvesting were apoptotic. Apoptotic 
cells can emerge when confluence arises(Long et al., 2003). The observation that the caspase- 3 cleavage of nuclear 
hMLH1 seems to correlate with the amount of full length hMLH1 found in the mitochondrial preparation raises the 
possibility that the presence of hMLH1 in mitochondria is connected to the process of apoptosis. This could be a 
plausible explanation since mitochondria, apart from playing an important role in energy metabolism, also are known to 
be involved in apoptosis. In addition hMLH1 has been shown to be indispensable in mediating an apoptotic signal after 
various DNA damaging treatments. To date, the possible signalling pathways linking hMLH1 and apoptosis however, 
remains unknown. Other MMR proteins like hMSH6 and hMSH2 have also been shown to mediate an apoptotic signal 
after treatment with various damaging agents (see section 2.3) 
 
Another explanation for the presence of hMLH1 in the mitochondrial extracts could be that hMLH1 is an artefact. If the 
cell cultures used were apoptotic at the harvesting time the nuclear envelope might be ruptured resulting in a possible 
leak of nuclear proteins, including those involved in MMR, into the cytosol. This increases the risk of mitochondrial 
extract being contaminated with nuclear proteins adhering to the outside of the mitochondria. 
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The main focus of this thesis is to confirm the results obtained by Houg et al. (2004) on the presence of MMR proteins 
in human mitochondria using new mitochondrial preparations of LoVo and HeLa together with the new hMLH1 
inducible cell line 293T-Tet-off-hMLH1. Furthermore it is tested whether the MMR protein hMSH3, a component of 
the MutSβ complex (see section 2.1), is present in the cell lines used. Furthermore, we will attempt to clarify whether 
the finding of hMLH1 and hPCNA in the mitochondrial extracts is actually due to mitochondrial import of either 
protein. For this purpose we intend to investigate whether hMLH1 and hPCNA are actually localized inside 
mitochondria, outside mitochondria or if they are associated with the mitochondrial envelope. Finally we will try to 
elucidate whether Mlh1 and Msh2 in the yeast S. cerevisiae are involved in repair of mtDNA after induction of 
oxidative damage. 
Hopefully our results will bring us one step further in establishing whether MMR proteins are actually found in human 
mitochondria, and if so, whether they are involved in mtDNA repair, or perhaps in modulating an apoptotic response. 
 
 
2 Theory 
 
In the following sections the basic principles of theory underlying our project will be reviewed. It will be explained in 
which way the MMR proteins are known to promote DNA repair in human cells and how these proteins are transported 
from the cytosol to the nucleus. Furthermore, using TRAIL and etoposide as examples, the extrinsic and the intrinsic 
apoptotic pathways will be presented. In addition, an overview of what is known so far about the involvement of MMR 
proteins in the process of apoptosis is given. Furthermore the destructive influence of oxidative damage on DNA will be 
described regarding the increased likelihood of DNA damage in the mitochondria, caused by oxygen and its derived 
radicals. 
 
2.1 Mismatch repair 
 
 
MMR proteins are encoded by the nuclear genome. These proteins have the ability to identify replication errors in 
nuclear DNA resulting in DNA mismatches which cannot base pair in a Watson-Crick manner and remove them to 
avoid accumulation of mutations and to maintain a stable genome (Stojic et al., 2004). MMR proteins are highly 
conserved in prokaryotes, as well as in eukaryotes. The MMR process is a postreplicative process, carrying out its 
function in immediate connection with the replication.   
The first investigations on MMR proteins were carried out in Escherichia coli (E. coli), where the MMR key proteins 
are called MutS, MutL and MutH (the names refer to the so called mutator phenotype). The MMR process in E. coli is 
initiated by the dimeric MutS protein which recruits dimeric MutL, and together they activate MutH, an endonuclease 
that cleaves the unmethylated strand at hemimethylated dGATC sites. Nicking of the unmethylated strand by MutH 
ensures that MMR targets repair to the newly synthesized strand containing the errors. The nick serves as a point of 
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entry for single stranded DNA binding protein and helicaseII, whose loading on the nick is facilitated via protein-
protein interactions with MutL (Schofield and Hsieh, 2003). 
 
 
Figure 2: Schematic presentation of the MMR process in mammalian cells. 
Misincorporation of thymidine (T), opposite guanine, during DNA replication gave rise to a G/T mismatch, which has to be corrected to G/C. 
The MMR process commences by the binding of MutSα, which undergoes an ATP-driven conformational change and recruits the MutLα 
complex, in an ATP-dependent manner. This complex can be translocated in either direction along the DNA strand (green arrows). When it 
encounters a strand discontinuity which is bound by PCNA (blue circle) loading of exonuclease1 (EXO1, red) initiates degradation of the 
nicked strand in the direction of the mismatch. The single-stranded gap can then be filled by the replicative polymerase and the nick is then 
sealed by DNA ligase (Stojic et al., 2004). 
 
 
The corresponding eukaryotic proteins are referred to as MutS and MutL homologues(Meyers et al., 2004). In humans 
the MMR pathway is initiated by the heterodimer MutSα, which is formed by MutS homologues hMSH2 and hMSH6, 
or by the less abundant heterodimer MutSβ (hMSH2 and hMSH3). These two complexes recognize mismatches on 
DNA, whereas MutSα specifically identifies base-base mismatches and single base insertion-deletion loops (IDL), 
MutSβ interacts with short IDLs of 1-16 nucleotides. MutL homologues also function as dimmers; it is known that 
hMLH1 dimerizes with hPMS2 (MutLα), but also forms complexes with hPMS1 and is then called MutLβ complex. 
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The MutLγ complex consists of hMLH1 combined with hMLH3, however, the function of this complex is not yet 
known. MutLα is the major MutL homologue in the MMR pathway, while MutLβ is only known to function in meiosis 
(Stojic et al., 2004). The pathway starts with the assembly of either MutSα or β on the DNA double strand and the 
further recruitment of MutLα. This ternary complex then moves along the DNA and stops when it finds a strand 
discontinuity that might be bound to PCNA (Paunesku et al., 2001; Stojic et al., 2004). PCNA is involved in the 
resynthesis step of MMR, but also interacts with both the MutSα and MutLα complexes(Marti et al., 2002). It has been 
pointed out that PCNA could also play a role in the localization process of MMR proteins in the area of the replication 
fork and in loading MutSα and MutSβ on to the mismatch(Lau and Kolodner, 2003). PCNA enrols exonuclease1 
(EXO1) which probably starts degradation of the nicked strand. If the exonuclease is disconnected before it reaches the 
mismatch, the single-stranded gap will be stabilised by the replication protein A (RPA).  
However, in eukaryotes no MutH homologue has been identified, so it is not known how the nick is introduced in the 
new strand towards the mismatch. The exonucleolytic digestion is initiated by assembly of MutSα and MutLα 
complexes. The mismatch is removed and the gap is filled by DNA polymerase δ, whereas the remaining nick is sealed 
by DNA ligase (Stojic et al., 2004). Besides the function in recognition and elimination of DNA mismatches MMR 
proteins are also known to be involved in other DNA damage repair pathways such as transcription-coupled repair, and 
double strand repair as well as recombination and separation processes of DNA (Stojic et al., 2004). 
So far, in higher eukaryotes all functions of the MMR systems seem to be carried out on chromosomal DNA. 
A proficient MMR system requires that all the necessary MMR proteins, after being translated in the cytosol, must be 
transported into the nucleus. The nuclear localization signal (NLS) is the sequence which is required for the nuclear 
import of proteins and is generally functional in targeting proteins to the nucleus. Previously it has been shown that the 
mismatch repair functions may be regulated by nuclear transport. (Wu et al., 2003) found that MLH1 and PMS2 
contains a NLS as well as a nuclear export signal (NES) and that the C-terminal dimerization is required for the nuclear 
localization of the MutLα , presumably because the NLS sequences are only exposed upon complex formation. 
Furthermore Brieger et al. (2005) investigated the NLS sequences of MutLα, by expressing NLS deficient mutants of 
hMLH1 and hPMS2 in 293T cells. They showed that human MutLα contains the NLS sequence and that mutations in 
this complex presumably lead to impairment of nuclear import.     
 
 
2.2 Apoptosis 
 
Apoptosis, the process of regulated cell death, is a genetically controlled process that can be triggered by intrinsic and 
extrinsic apoptotic stimuli (Yang et al., 2001). Both the intrinsic- and extrinsic pathways of apoptosis rely on activation 
of caspase-s (Meyers et al., 2004). Caspase-s constitute a specific family of proteases, which cleave their substrate 
between cysteine and aspartate residues, and they play a central role in the initiation and execution of apoptosis(Ashe 
and Berry, 2003). It appears that caspase- 3 plays a critical role in both pathways (Kondoh et al., 2005; Yang et al., 
2001). Studies conducted by Chen et al. (2004) showed that apoptosis initiated by drugs like etoposide and TRAIL 
resulted in specific cleavage of hMLH1 by caspase- 3. In addition, mutation of the caspase- 3 cleavage signals in 
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hMLH1 abrogated the initiation of apoptosis after treatment with etoposide. Furthermore, activation of caspase-3 will 
be emphasised. 
 
2.2.1 The extrinsic and intrinsic pathway of apoptosis 
  
The extrinsic pathway, also called the death receptor pathway, is mediated by proteins belonging to the tumour necrosis 
factor (TNF) superfamily (Meyers et al., 2004; Wagner et al., 2004). TRAIL, which is a member of the TNF family, 
transmits an apoptotic signal when it binds to and trimerizes with death receptor 4 (DR4) and death receptor 5 (DR5), 
respectively. Binding of TRAIL to the two death receptors leads to the recruitment of the adaptor molecules Fas-
associated death domain (FADD) and pro-caspase-8. These two molecules dimerize to a complex called death inducing 
signalling complex (DISC) (Ashe et al., 2003; Broaddus et al., 2004). This dimerization and a subsequently cleavage 
activates pro-caspase- 8 which afterwards activates downstream executioner caspase-s such as caspase- 3 (Broaddus et 
al., 2004). 
The way caspase- 8 affects downstream proteins depends on the cell type. In some cell types caspase- 8 activates 
caspase- 3 directly and in other cell types caspase-8 links the extrinsic pathway to the intrinsic pathway by cleavage of 
Bid which is a member of the pro-apoptotic family Bcl-2 (Wagner et al., 2004). Proteins of the Bcl-2 family can either 
support or prevent signalling of apoptosis by forming homo- or heterodimers and thereby influence the regulation of 
apoptosis. 
The Bcl-2 family consists of both anti- and proapoptotic members that possess conserved α-helices with sequence 
conservation clustered in Bcl-2 homology (BH) domains. The anti-apoptotic subfamily includes members like Bcl-2, 
Bcl-xL, MCL-1, A1 and Bcl-w, which promote survival of cells. Proteins inducing cell death are Bax, Bak, Bcl-xS, 
Bok, BIK, BNIP, Bad, Bid and Bim (Kim et al., 2004). Bid is activated when cleaved by caspase- 8, producing 
truncated Bid (Banerjee and Ghosh, 2004a). tBid triggers the release of the electron carrier protein cytochrome c from 
the outer mitochondrial membrane to the cytosol by interaction with Bax, which in turn forms a heterodimer with Bak. 
The Bcl-2 protein can prevent the signalling cascade leading to apoptosis through interaction with Bax. Thereby the 
Bax protein becomes neutralized resulting in an interruption of the cascade. Released cytochrome c associates with 
apoptotic protease activation factor 1 (ApaF-1) and caspase- 9 resulting in the formation of an apoptosome leading to 
the activation of caspase- 9 and finally caspase- 3 (Wagner et al., 2004 ; Ashe et al., 2003).  
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Figure 3: The extrinsic and intrinsic pathway of apoptosis. The extrinsic pathway is induced through TRAIL, activating caspase- 8 or 10, 
while the intrinsic pathway mainly includes cytochrome c release from the mitochondria. Both pathways unite in the activation of caspase-3, 
through Bid (Benedict et al., 2002). 
 
The intrinsic apoptotic pathway is initiated by internal sensors that monitor cellular stress for example induced by 
etoposide, an anticancer drug, which is known to activate pro-caspase- 8, which then activates pro-caspase- 3. 
Etoposide is capable to initiate the intrinsic pathway by translocation of Bax to the mitochondria, where Bax initiates 
the release of cytochrome c which binds to ApaF-1 and pro-caspase- 9. Autocatalytic activation of caspase-9 initiates 
the effector caspase cascade, which includes caspase-2,-3,-6 and -7 (Karpinich et al., 2002). 
Etoposide is also known as a topoisomerase II inhibitor which is an anti-neoplastic drug used to couple DNA-damage to 
apoptosis. The inhibition of topoisomerase II results in the accumulation of DNA double strand breaks which activates a 
DNA dependent protein kinase (DNA-PK), a member of the PI3-kinase family that activates the tumour suppressor 
gene p53 by phosphorylation (Karpinich et al., 2002). p53 in turn induces apoptosis by activating transcription of 
numerous genes involved in apoptosis. This protein is said to be involved in both the intrinsic and extrinsic pathway of 
apoptosis (Ashe and Berry, 2003). 
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2.2.2 MMR proteins and apoptosis 
 
As mentioned, the MMR proteins are a set of highly conserved proteins which are responsible for the elimination of 
nucleotide mispairs. The idea, that MMR proteins could also be involved in the process of apoptosis first came up, 
when a reduced sensitivity to cytotoxic alkylating DNA damaging agents in MMR defective tumour cells was observed 
(reviewed in Fedier et al., 2004). Exposing MMR defective mice to alkylating agents, showed defective responses in 
Pms2, Msh2 and Mlh1 null cells. But, the results also showed damage-specific and gene dose-dependent differences in 
the requirement for each of the named proteins. High levels of alkylation damage required Msh2, while low levels of 
damage showed the need for Mlh1 and Pms2 for signalling to the apoptotic cascade(Sansom et al., 2003). MMR 
deficiency, loss of hMLH1 in particular, in general seems to be associated with reduced levels of apoptosis, but higher 
levels of survival of damaged cells. This allows mutations to occur at high rates, because there is no selection against 
cells with severely mutated genes. Presumably this promotes the development of cancer.   
Takagi et al. (2003) investigated if the genotype (+/+, -/- or +/-) of MLH1 protein plays a role in alkylation-induced 
apoptosis and mutagenesis. The alkylation repair enzyme, O6-methylguanine-DNA methyltransferase(Takagi et al., 
2003), which normally removes alkylated bases in the mouse fibroblast cells used, was knocked out (Mgmt -/-). Western 
Blot analysis showed that homozygous MLH1 cells also contained comparable amounts of PMS2, the 
heterodimerization partner in MutLα formation, while in MLH1 heterozygous fibroblast cell, the amount of PMS2 was 
decreased to half the amount of MLH1. MLH1 deficient cells did not show any PMS2 content. The concentration of 
MutS homolog MSH2 was not affected by the Mlh1 genotype. The survival rates of the cell lines used showed that 
Mlh1 +/+ cells are highly prone to mortality at relatively low levels of cytoxiticity caused by the methylating agent, 
MNU. Interestingly, Mlh1 +/- and Mlh1 deficient cells showed very similar survival rates. These results are supported 
by a caspase-3 activity assay after MNU treatment. Here, the Mlh1 +/+ cells showed an increased reactivity compared to 
the Mlh1 heterozygous and deficient cells, which in contrast showed no induction of caspase-3 and in conclusion no 
apoptotic signal.  
Since the initial findings, tests with MMR-deficient cells have shown their high tolerance towards many types of 
anticancer agents, such as cisplatin, alkylating agents, methotroxate, DNA topoisomerase II inhibitors, oxidative stress 
and 5-fluorouridine (Yanamadala and Ljungman, 2003) 
As mentioned, it has recently been reported that MLH1 has been identified as a specific substrate for caspase-3 when 
cells are induced to undergo apoptosis by treatment with TRAIL or etoposide(Froelich-Ammon and Osheroff, 1995). 
Cleavage of caspase-3 is also mentioned to cause partial relocalization of MLH1 from the nucleus to the cytoplasm by 
production of a proapoptotic carboxyl-terminus.  
Treatment of HCT116 (hMLH1-/-) and HCT116 + Chr. 3(hMLH1+/+) colorectal cancer cells with the alkylating agents  
N-methyl-N-nitrosourea (MNU) and N-methyl-N-nitro-N-nitrosoguanidine (MNNG) causes DNA damage in an 
hMLH1-dependent manner. This has been found to happen in correlation with cell cycle-independent phosphorylation 
of p53 at Ser-15 and apoptosis(Yanamadala and Ljungman, 2003).  
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Duckett et al. (1999) found that O6 methylguanine forming agents can cause phosphorylation of p53 on serine residues 
15 and 392, and depending on the presence of functional MutLα and MutSα complexes. In addition, it was shown that 
the Mlh1-Pms1 heterodimer regulates p53 in mice (Meyers et al., 2004). 
At present the exact mechanism, by which MMR proteins mediates apoptosis not yet understood, but it seems that 
MMR proteins activate the tumor suppressor protein p53 in response to radiation and other DNA damages. The 
mechanism of how MMR proteins trigger p53 and apoptosis still remains unclear, but it is evident that the MMR 
proteins play a pivotal role in the triggering of an apoptotic response to various DNA damages. 
 
 
 
2.3 Oxidative damage 
 
This section shortly reviews the process of oxidative damage and the repair pathways involved in the correction of 
mtDNA lesions induced by this kind of damage. Special emphasis is put on the proteins relevant for the conducted 
erythromycin assay. 
Reactive oxygen species (ROS) can be generated from both endogenous and exogenous sources(Huang and Kolodner, 
2005). In all organisms endogenous ROS are continually formed as a by-product from normal metabolism while 
exogenous ROS originate from exposure to various environmental factors(Stevnsner et al., 2002). In aerobic organisms 
the major endogenous source of ROS is the electron transport chain localized in the inner mitochondrial membrane (Lee 
and Wei, 2005; Van Houten et al., 2005). During electron transfer, especially at the site where NADH dehydrogenase 
and the Quinones function, a significant number of electrons may leak from the chain resulting in the formation of ROS 
such as superoxide-, hydrogen peroxide- and hydroxyl radicals (Lee and Wei, 2005; Van Houten et al., 2005). It has 
been estimated that human cells metabolize approximately 1012 oxygen molecules on a daily basis when normal 
oxidative phosphorylation takes place and around 1% of these oxygen molecules results in the formation of ROS(Ikner 
and Shiozaki, 2005). To limit the number of ROS molecules, mammalian cells are equipped with antioxidant defences 
that scavenge and inactivate ROS(Huang and Kolodner, 2005). Hydrogen peroxide, for example, is normally broken 
down by the enzyme glutathione peroxidase, but if the glutathione pool is depleted or if hydrogen peroxide is produced 
in excess, this radical is able to escape the defences potentially damaging macromolecules including DNA, inducing 
various kinds of lesions, as for example, base modifications (Huang and Kolodner, 2005; Van Houten et al., 2005). In 
mtDNA ROS can produce over a 100 types of base modifications (Singh et al., 2001). The damaged form of guanine, 8-
oxo-guanine (8-oxo-G), is one of the most abundant base lesions caused by oxidative damage (Mazurek et al., 2002). 
Calculations have shown that approximately 1000 8-oxo-Gs residues per genome are generated on a daily basis in 
human cells (Kunkel et al., 1999). DNA-polymerase γ, which, as mentioned, is the only DNA polymerase detected in 
mammalian mitochondria until now, will incorporate a wrong base, often adenine, opposite 8-oxo-G approximately 
27% of the time (Pinz et al., 1995). In the next round of replication, adenine incorporated in the template strand, will be 
paired with thymine and thus a GC base pair is converted to a TA base pair (Mazurek et al., 2002). If not repaired, such 
errors can be implicated in the process of aging, in the development of cancer or different inheritable diseases (Bohr, 
2002; Luft, 1994).     
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Investigations on numerous cell types from yeast, mice, rats and humans have shown that mtDNA is 3-10 fold more 
prone to oxidative damage than nDNA (Van Houten et al., 2005). The higher vulnerability can be explained by the 
close proximity of mtDNA to endogenous ROS leaking from the electron transport chain (Croteau et al., 1999). 
Furthermore, human mtDNA does not contain any introns or protective histone proteins like nDNA. Finally the higher 
vulnerability in mitochondria can be a result of its limited capacity for DNA repair (Lee and Wei, 2005).  
To date little is known about the repair pathways present in mitochondria whereas insight into the nuclear repair 
pathways is fairly good (Bohr et al., 2002). In this section only repair pathways involved in the repair of oxidative 
damage will be mentioned. BER is the only repair system that has been proven to exist in mitochondria (Bohr et al. 
2002). The before mentioned 8-oxo-G lesion is repaired mainly through the BER pathway(Barzilai and Yamamoto, 
2004). The BER pathway is mediated by a number of glycosylases. These glycosylases have different specificities for 
different kinds of lesions (Tudec, 2003). One of them, 8-oxo-G-glycosylase (Ogg1) (Singh et al., 2001), is a 
bifunctional glycosylase which recognizes and removes the damaged base. Ogg1 has an associated lyase activity which 
means that the protein cleaves the resulting abasic site, generating a single strand break. The single strand break is 
further processed by DNA polymerase and DNA ligase (Fortini et al., 2003). A study conducted by de Souza-Pinto et 
al. (2001) showed that Ogg1 in mitochondria actually plays a more important role in the avoidance of mutations than in 
the nucleus. This statement was based on the fact that accumulation of 8-oxo-G in the DNA of Ogg1 deficient animals 
was higher in the mitochondria than in the nucleus when compared to the wild type.     
Another repair system that has been shown to be involved in the avoidance of nuclear mutations caused by oxidative 
damage is the MMR system (Mazurek et al., 2002). Experiments conducted using the yeast S. cerevisiaehave revealed 
that MMR in the nucleus seems to prevent incorporation of wrong bases opposite oxidative damaged bases such as 8-
oxo-G (Ni et al., 1999). For example investigations revealed that the Msh2-Msh6 complex, present in the nucleus, binds 
specifically to 8-oxo-G:A and 8-oxo-G:C mismatches (Ni et al., 1999). In addition, combinational mutations in Msh2 or 
Msh6 together with Ogg1 results in a synergistic increase in the number of nDNA mutations, suggesting a functional 
overlap between MMR and Ogg1 (Ni et al., 1999). Also the level of Msh1, which until now has not been found in 
higher eukaryotes, seems to play an important role in the avoidance of mutations in mtDNA caused by oxidative 
damage(Dzierzbicki et al., 2004). Yeast cells over-expressing Msh1 have been associated with a decreased amount of 
transversions in mtDNA, suggesting that Msh1 could be implicated in the repair of GC→TA transversions caused by 8-
oxo-G lesions(Dzierzbicki et al., 2004). Dzierzbiki et al. (2004) proposed that Msh1 might play a similar role in the 
mitochondria as that exerted by the Msh2-Msh6 complex in the nucleus. Whether mitochondria harbour a MMR system 
similar to the one known in the nucleus is however still not clear (Larsen et al., 2005). 
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3 Materials and Methods 
 
In this section the experimental procedures, materials and cell cultures used in the present study are listed.  
 
3.1 Cell Cultures 
 
To verify the previously obtained results by Houg et al. (2004) new preparations of the hMSH2 deficient colon cancer 
cell line LoVo, and the MMR proficient cervical cancer cell line HeLa are used. In addition, the present study includes 
the cell line 293T-Tet-off-hMLH1 which comprises human embryonic kidney cells containing an inducible hMLH1 
allele(Cejka et al., 2003). In table 1 some characteristics of the chosen cell lines have been outlined. 
 
 SW480  LoVo HeLa 293T-Tet-off-
hMLH1 
HCT116 
+ chr. 3 
Cell type Colorectal 
Carcinoma 
Colorectal 
carcinoma4 
Cervical 
carcinoma1 
Embryonic 
kidney5 
Colorectal 
carcinoma2 
MMR 
deficiency 
-2 hMSH24 -3 -5 -2 
p53 status -2 +4 + +5 +2 
MSI -2 +4 - -5 -2 
Antibiotic 
resistance 
   Zeocin, 
Hygromycin5 
Geneticin2 
Regulation    Tetracycline, 
Doxycycline5 
 
Purchased 
from 
American 
Type 
Culture 
Collection 
(ATCC) 
American 
Type 
Culture 
Collection 
(ATCC) 
American 
Type 
Culture 
Collection 
(ATCC)1 
Provided by 
Josef Jiricny, 
University of 
Zürich, 
Switzerland5 
Laboratory 
stock 
Table 1: Listed are the phenotypic characteristics of MMR, p53, the stability of microsatellite repeats together with antibiotic resistance and 
regulation possibilities in the human cell lines used in the present study. 1Akiyama, 1987, 2Koi et al., 1994, 3Boyer et al., 1995, 4Gayet et al., 
2001, 5Cejka et al., 2003. 
 
The LoVo cell line is hMSH2 deficient due to a homozygous deletion on chromosome 2 ranging from exon 3 to exon 8 
in the hMSH2 gene. This damage leads to MMR deficiency and a high frequency of mutations in microsatellite loci.  
The 293T-Tet-off-hMLH1-cell culture originates from the hMLH1 deficient cell line 293T. In 293T the hMLH1 gene 
has been epigenetically silenced by hypermethylation of the hMLH1 promoter (Trojan et al., 2002). In the 293T-Tet-
off-hMLH1 cell line the hMLH1 gene can be turned on or off. This is done by introducing a vector encoding a 
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tetracycline-controlled trans activator (Paunesku et al., 2001) (Paunesku et al., 2001). Afterwards a vector carrying 
hMLH1 cDNA controlled by a tetracycline response element (TRE) was added. When tetracycline, or the more stable 
analogue doxycycline (DOX) is added to the culture medium, it binds to tTA and induces a conformational change 
causing tTA to dissociate from the TRE promoter thereby inactivating transcription of hMLH1(Singh et al., 1999). 
When DOX is absent tTA binds to TRE and thus activates transcription of hMLH1. The hMLH1 is actually over-
expressed in the 293T-Tet-off-hMLH1-cell line but this over-expression does not seem to have any side effects (Cejka 
et al., 2003). 
To identify whether hMLH1 and hPCNA are found outside or inside mitochondria the cell culture HCT116 + chr. 3 and 
SW480 have been chosen. HCT116 + chr. 3 and SW480 are both MMR proficient. HCT116 + chr. 3 originate from the 
hMLH1 deficient cell line HCT116 that contains a defect hMLH1 gene on chromosome 3 due to a homozygous 
mutation. The deficiency is corrected by introducing an extra chromosome containing a wild type hMLH1 allele, 
originating from normal human fibroblasts, into HCT116. Introduction of chromosome 3 into HCT116 resulted in 
stabilization of microsatellites, suggesting that the introduced hMLH1 allele restores a functional MMR system. In 
addition, the hMLH1 allele renders cells sensitive to MNNG (Koi et al., 1994). Mitochondrial and nuclear cell extracts 
were kindly provided by Morten Riser Nielsen and Tinna Stevnsner, Aarhus University, Denmark. The purification of 
mitochondrial and nuclear extracts had been conducted after growth of a large number of cells. These were 
homogenized and the mitochondrial and nuclear fractions were separated and purified by repeatedly centrifugations and 
following resuspension in appropriate buffers. When mitochondrial and nuclear fractions were separated, the protein 
concentration was measured and the purified batches stored at -80ºC.       
It should be noticed that it is possible that the cell lines used in the conducted experiments might have unknown defects. 
 
3.2 Western blot analysis 
 
Materials  
Primary antibodies: Mouse anti-hMLH1; Pharmingen (Cat No. ss4073). Mouse anti-α-MSH2 (ab2); Calbiochem. 
Mouse anti-MSH3 MAb (Cat No.611390); Pharmingen. Rabbit α-GTBP anti-MSH6 (H141); Santa Cruz Biotechnology 
(Cat No. sc10798). Mouse anti-PMS2; Pharmingen (Cat No.556415). Mouse anti-PCNA; Santa Cruz Biotechnology 
(Cat No. sc-56). 
Secondary antibodies: anti-mouse (Cat No. 172632) and anti-rabbit (Cat No.172631); Amersham LifeScience. 
Mercaptoethanol; Sigma. Gel apparatus and nitrocellulose membranes; BioRad. PAGEr Duramide Pre-cast SDS-
polyacryl amide gels; Cambrex Bioscience. Non-fat milk; Beckton Dickinson. X-ray film; Amersham Bioscience. 
SuperSignal kit; Pierce. Loading buffer, running buffer, sponges, 3 MM filter paper, blotting buffer, 1 x TBS-T, 
Ponceau red, 1% acetic acid, cassette, developing solution, fixing solution; laboratory stock.   
 
Method 
To determine the presence of hMLH1, hMSH2, hMSH3, hMSH6, hPMS2 and PCNA in mitochondrial extracts from 
LoVo, HeLa and 293T-Tet-off-hMLH1, purified mitochondrial extracts were separated on a SDS-polyacryl amide gel 
and finally visualised after conducting a Western Blot.  
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Appropriate volumes of protein extracts were mixed with H2O, 2 x loading buffer and 1/10 volume mercaptoethanol to 
a final volume of 20 µl containing 20- or 40 µg of protein. The samples were heated to 95ºC for 2 minutes before they 
were loaded on a 7,5% or 12% pre-cast SDS-polyacryl amide gel dependent on protein size. 5 µl of the size marker 
Prosieve was also loaded. Electrophoresis was run at 125 V in 1 x SDS running buffer for approximately one hour. 
After dissembling the gel apparatus, gel, sponges, 3 MM filter papers and the nitrocellulose membrane were immersed 
in blotting buffer for 15 minutes. The blotting sandwich was assembled according to the manufacturers instructions and 
run at 100 V for one hour under stirring and additionally cooled with an ice reservoir. Afterwards the nitrocellulose 
membrane was stained with Ponceau Red for one minute and subsequently washed in 1% acetic acid until the 
background appeared white. The visualized smear of protein extracts was photocopied and the membrane was blocked 
over night in approximately 30 ml 5% non-fat milk/1 x TBS-T solution at 4ºC. Next day the blocking solution was 
replaced with 10 ml of 5% non-fat milk/1 x TBS-T solution containing primary antibody in the appropriate 
concentration. The membrane was incubated for one hour in room temperature on a rocking platform. Afterwards the 
membrane was washed 2 x 2 minutes and 3 x 10 minutes with 100-200 ml 1 x TBS-T solution on a rotating platform. 
Following the washing step the membrane was incubated for one hour on a rocking platform under room temperature in 
a 10 ml 5% non-fat milk/1 x TBS-T solution now containing the appropriate concentration of secondary antibody. The 
washing step was repeated. Proteins recognized by the antibody were visualized with a SuperSignal kit according to the 
manufacturers instructions. After having exposed the membrane to approximately 7 ml of SuperSignal Solution for 5 
minutes, the membrane was wrapped in Witawrap and visualized on X-ray film in a cassette for a variable amount of 
time depending on the intensity of the signal. The X-ray film was then placed in developing solution and moved to 
fixing solution when the result seemed satisfying (usually from 1-5 minutes). After 5 minutes of incubation in fixing 
solution, the X-ray film was transferred to demineralised H2O where it was soaked for at least an hour.  
 
 
3.3 Proteinase K treatment  
 
Materials: 
Spermidine, GST-hMLH1, Sucrose, EDTA, Tris-HCL, PMSF and proteinase K; laboratory stock. 
 
Method 
To establish whether hMLH1/PCNA is located inside mitochondria or if these proteins are associated with the 
mitochondrial envelope, both sonicated and non-sonicated mitochondrial extracts from the hMLH1 proficient cell line 
HCT116 + chr. 3, and the MMR proficient cell line SW480 (both extracts are aliquots of the extracts used by Houg et 
al. 2004) were treated with protease K before conducting electrophoresis and western blot. Approximately 80-120 µg 
mitochondrial extract was dissolved in 200 µl wash buffer. The solution was separated into two 100 µl aliquots named 
A and B. A was kept on ice while B was sonicated on ice 3 times 5 seconds at 1 minute intervals. Both aliquots were 
spinned down at 16100 g for 2 min at 0ºC. The supernatant was removed and the pellet dissolved in 20 µl wash buffer. 
Aliquot A and B were both separated into two further aliquots of 10 µl each. The aliquots were named A1, A2, B1 and 
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B2. To the A1 and B1 aliquots 2 µl of H20 were added and the solution was kept at 0ºC for 20 minutes. After this time 
period 1 µl of PMSF protease inhibitor was added and the solution was incubated at 0ºC for 10 minutes. The A2 and B2 
aliquots were incubated at 0ºC for 20 minutes with 2 µl proteinase K and afterwards treated with 1 µl PMSF for 10 
minutes. As a control for the procedure two aliquots containing 1 µg purified GST tagged hMLH1 protein were 
dissolved in 10 µl wash buffer and treated with H2O and proteinase K respectively at 0ºC for 20 minutes. Afterwards the 
samples were incubated for 10 minutes with PMSF. When all samples were ready an appropriate volume of 2 x loading 
buffer was added and the samples were heated to 95ºC for 2 minutes and finally loaded on the SDS-polyacryl amide 
gel. The electrophoresis- and the blotting procedure were conducted under the same conditions as before mentioned in 
the previous section. 
 
 
3.4 Erythromycin resistance assay 
 
Materials 
Bacto Yeast Extract and Bacto Peptone; Difco Laboratories.  
Glycerin; Bie & Berntsen A-S. Agar-Agar; Merck. YPD agar medium; BD Biosciences Clontech. Erythromycin; 
BioChemika. Na2HPO4 and KH2PO4; laboratory stock. 
 
Strain and Media 
The S. cerevisiae strains used in this study was derived from BY4741. Following genotypes was used in the experiment; 
wild type (Y0), Mlh1-/- (Y750), Msh2-/- (Y6240), Ogg1-/- (Y510). The strains were grown in N3-medium containing 
glycerol (unfermentable) to avoid growth of respiratory incompetent cells. 
 
Method 
Indicated strains were inoculated from laboratory stock onto N3-plates. After an appropriate number of days with 
incubation at 30ºC, individual colonies were inoculated in 5 ml N3-medium. For each set of experiments three 
independent cultures were grown one to two days in a water bath at 30ºC under vigorous shaking. The following day 
OD600 was measured and the cultures were diluted into fresh growth medium to a final OD600 of 0,15. Cultures were 
allowed to grow into log phase at an OD600 of 0,4-0,5 to ensure homogene and viable cells and then incubated for one 
hour with 2 mM of menadione introducing oxidative damage. 200 µl of appropriate culture dilutions were plated onto 
YPD plates to determine the number of viable cells. 10 ml culture were spinned down at 4000 rpm, washed in 2 ml 
sterile water, vortexed, spinned down again and finally plated onto solid N3-medium containing erythromycin for the 
determination of erythromycin resistant cells. Colonies grown at solid YPD were scored after three days while colonies 
grown at erythromycin containing N3-plates were scored after 10 days of incubation. The number of mutations was 
calculated as the number of erythromycin resistant colonies divided by the total number of colonies and presented as the 
average number of ER colonies per 108 cells in the culture.  
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4 Experimental strategies and results 
 
In this section, a description of the experimental strategy is provided, followed by a presentation of the results obtained. 
The presentations of the results include a summary of the expected outcome of the experiment, as well as an evaluation 
of the data obtained. 
 
4.1 Western Blot analysis of MMR proteins 
 
 
The western blot analysis is conducted on new mitochondrial and nuclear extracts from LoVo and HeLa cell lines, as 
well as on mitochondrial extract from the 293T-Tet-off-hMLH1 cell line. Unfortunately, it was not possible to get a 
nuclear extract originating from the 293T-Tet-off-hMLH1-cell line. The nuclear extracts function as controls of the 
experimental procedure, and, for the hMLH1 experiments, also as a measure of whether the used cell lines were 
apoptotic at the time of harvest. The mentioned extracts have all been examined for the presence of MMR proteins, 
including hMSH2, hMSH6, hMLH1, hPMS2 and hPCNA, also tested for by Houg et al. (2004). The hMSH2, hMSH6, 
hMLH1, and hPMS2 proteins have been chosen because they play a central role in the nuclear MMR pathway. hPCNA 
is interesting because it is involved in MMR and unexpectedly appeared in most of the mitochondrial extracts 
investigated by Houg et al. (2004). A new investigation on the presence of hPCNA in the mitochondria of LoVo and 
HeLa together with an investigation of its presence in mitochondrial fractions from the cell line 293T-Tet-off-hMLH1 
aims to clarify this result. For a description of the MMR proteins in general see section 2.1. The stability of hMSH6 and 
hPMS2 is dependent on the presence of their respective partners hMSH2 and hMLH1. If hMSH2 or hMLH1 is not 
present to form their heterodimers, hMSH6 and hPMS2 will be degraded. Therefore it is expected that the hMSH2 
deficient LoVo cell line, which in this context is used as a negative control for hMSH2, will not contain any hMSH6 
protein. As mentioned before, the 293T-Tet-off-hMLH1-cell culture over-expresses hMLH1, which is why the total 
level of hMLH1 in this cell line presumably will exceed the level of hMLH1 in LoVo and HeLa (Cejka et al., 2003). 
The different cell lines have also been tested for the presence of hMSH3, which together with hMSH2 comprises the 
MutSβ complex. Antibody against hMLH3 was kindly provided by the Pathology Department at Rigshospitalet where it 
had been used for immunohistochemistry. However, the antibody did not seem to work for this purpose. Before the 
antibody against hMSH3 could be used for Western Blotting experiments it was necessary to determine the appropriate 
concentration ratio between the primary and secondary antibody. A titration of hMSH3 antibody was conducted on 
nuclear extracts from the MMR proficient cell line SW480 and the hMSH2 deficient cell line LoVo. Since SW480 is 
MMR proficient it should contain hMSH3 in the nucleus, while LoVo functions as a negative control since hMSH3 is 
expected to be degraded because its MutSβ partner hMSH2 is not present. (For the same reason hMSH3 is not expected 
to be present in the mitochondrial fractions of LoVo). If hMSH3 is present in nuclear extracts of MMR proficient HeLa 
it is expected to be present in smaller amounts than hMSH6(Drummond et al., 1997).   
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In the present study, using COXII antibody, the nuclear extract was tested for mtDNA contamination. COXII is a 
protein encoded and synthesized in the mitochondria and should, if no contamination has occurred, only be present in 
the mitochondrial extracts. Conversely, it would have been optimal if the mitochondrial extracts were tested for 
contamination with nDNA. This was tried by Houg et al. (2004) with an antibody against lamin A/C, a nuclear specific 
protein. However, despite several attemps to find the optimal antibody dilutions, this antibody did not recognize a 
protein of the right size, and was therefore not useful.  
4.2 Results 
 
The cell extracts used in these experiments are nuclear and mitochondrial extracts from the LoVo and HeLa cell lines. 
In addition new mitochondrial extracts from 293T-Tet-off-hMLH1 cells, which over-express hMLH1, were also tested. 
However, results from this extract should provide some insight into whether over-expression of hMLH1 could result in 
mitochondrial localization of this protein.The main points of interest in these experiments were to verify the presence of 
hMLH1 and hPMS2 in mitochondrial extracts of LoVo mitochondrial fraction, as shown by Houg et al. (2004). As we 
have obtained fresh extracts from Stevnsner and Riser, tests were carried out for all previously tested MMR proteins. 
Additional tests were made to determine if the previously untested hMSH3 protein can be found in mitochondrial 
extracts of the tested cell lines. 
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4.2.1 Western Blot of hMSH2  
 
 
Figure 4: Ponceau Staining and Western Blot detection of hMSH2. 
Membrane was incubated with primary antibody anti-hMSH2 concentration of 1:500 and secondary antibody concentration of 1:10000 
(anti-mouse) (see materials and methods). 
 
 
Figure 4 shows the Western Blot of hMSH2 carried out on the different cell lines, as mentioned in the experimental 
strategies section. As can be seen from the Ponceau Staining, rather unequal amounts of protein are loaded in the lanes, 
particularly in the HeLa and LoVo mitochondrial lanes. The Western Blot shows a single band in the lane with HeLa 
nuclear extract, at approximately 105 kDa. These results indicate that hMSH2 is not present in the mitochondria of the 
hMSH2 proficient HeLa cell line, but is present in the HeLa nuclear fraction, as expected. Furthermore, neither LoVo 
extracts contained any hMSH2, as expected. Also, no hMSH2 was found in the mitochondrial extracts of the 293T-Tet-
off-hMLH1 cell line, which is hMSH2 proficient. As too little protein was loaded in the HeLa mitochondrial lane, 
minute amounts of hMSH2 in these mitochondria may theoretically have escaped detection. It can, however, be 
excluded that large amounts of hMSH2 are present in HeLa mitochondria. 
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4.2.2 Western Blot of hMSH6 
 
 
Figure 5: Ponceau Staining and Western Blot detection of hMSH6. 
Membrane was incubated with primary antibody anti-hMSH6 concentration of 1:500, and secondary antibody concentration of 1:10000 
(anti-mouse) (see Materials and methods). 
 
 
The Western Blot shown was tested with hMSH6 antibody. Only in the HeLa nuclear fraction a faint band was visible 
at the appropriate size of ~160 kDa. As mentioned, the protein was not expected to be recognized in LoVo extracts, as 
this cell line is deficient in hMSH2, and therefore hMSH6 would not be expected either. As can be seen from the 
Ponceau Staining there were equal amounts of protein loaded on the SDS gel, except for the lane containing HeLa 
mitochondrial extract, which is significantly weaker. Thus, it cannot be concluded from this experiment whether 
hMSH6 is present or absent in HeLa mitochondria. 
Together, the two experiments show that hMSH2 and perhaps hMSH6 are absent in HeLa mitochondrial fractions (see 
fig. 4 and 5). This indicates that MutSα does not exist in mitochondria of this cell line, which means that mitochondria 
seem to be deficient in a classical MMR system. It is interesting that the band of hMSH6 in the nuclear fraction is much 
fainter than the one discovered for hMSH2. As they are known to dimerize it would have been expected to find them in 
equal amounts. A possible explanation for this might be that for hMSH6 the concentrations of primary and secondary 
antibody were not set up in an optimal way. This suggests that titration experiments, to find appropriate ratios for both 
antibodies, should be carried out. Alternatively, the hMSH6 antibody may not work as efficiently at the hMSH2 
antibody, regardless of the concentrations used. 
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4.2.3 Western Blot of hMLH1 
 
 
 
Figure 6:  Ponceau Staining and Western Blot detection of hMLH1. 
Membrane was incubated with primary antibody anti-hMLH1 concentration of 1:500, and secondary antibody concentration of 1:10000 
(anti-mouse) (see Materials and methods). 
 
In this blot, bands at a size of ~87 kDa are observed in HeLa and LoVo nuclear extracts. The presence of hMLH1 in 
nuclear extracts of HeLa and LoVo is expected, as both these cell lines are hMLH1 proficient. A very faint band of 
hMLH1 can be detected in the HeLa mitochondrial fraction, but not in the LoVo mitochondrial fraction. However, a 
clear band at ~87 kDa is observed in the 293T-Tet-off-hMLH1  mitochondrial fraction, even though only low amounts 
of protein seems to have been loaded, based on the Ponceau Staining of the membrane. 293T-Tet-off-hMLH1 cells 
massively over-express hMLH1 proteins when DOX is not added.  
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4.2.4 Western Blot of hPMS2 
 
 
Figure 7:  Ponceau Staining and Western Blot detection of hPMS2. 
Membrane was incubated with primary antibody anti-hMSH6 concentration of 1:1000, and secondary antibody concentration of 1:10000 
(anti-mouse) (see Materials and methods). 
 
 
In this experiment, extracts were tested for the presence of hPMS2 protein. In the blot, a clear band at the expected 
~115 kDa can be seen in the HeLa nuclear fraction. Three very faint bands can also be observed in the LoVo nuclear 
lane at sizes of ~120, ~80 and ~60 kDa, but none of them are stained as intensely as the hPMS2 band in HeLa nuclear 
fraction, neither do they match the appropriate size of 115 kDa.  
A band for hPMS2 was expected in LoVo nuclear extracts, as this cell line is only deficient in hMSH2 protein, and a 
band for the MutLα interaction partner hMLH1, was found. Houg et al. (2004) also observed a pattern of three distinct 
bands in the LoVo nuclear extract. In contrast to our results, the results obtained previously showed bands at sizes of 
~115, ~76 and ~50 kDa. Since the two lower bands fit pretty much to the recently obtained results, it seems likely that 
the differences in size might be due to unequal running of the gel, which can be seen on the Ponceau Staining. The 
smaller fragments are probably due to proteolytic degradation, which has already been suggested by Houg et al. (2004), 
because addition of the two different sized fragments results in approximately the size of full length size hPMS2. A 
proteolytic degradation of hPMS2 is hardly due to lack of its complexing partner, as plenty of unprocessed hMLH1 was 
present in the same nuclear LoVo extract, see fig.6. Neither the HeLa nor the 293-off mitochondrial extracts showed 
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visible amounts of hPMS2, but judged from the Ponceau Staining these lanes were loaded with too little protein. Thus it 
cannot be excluded that small amounts of hPMS2 might be present in these two extracts. 
 
4.2.5 Titration of hMSH3 antibody 
 
 
Figure 8:  Ponceau Staining and Western Blot detection of hMSH3.  
Membrane was incubated with mouse primary and secondary antibody. For concentrations, see Materials and methods section. 
 
 
Figure 7 shows the Western Blot of the titration using hMSH3 antibody. Lane SW480 in section B shows the highest 
intensity at ~125 kDa compared to the other sections. In this section the first antibody was added at a concentration of 
1: 500 and the secondary antibody at a concentration of 1: 5000. Thus, it has been demonstrated that the antibody is 
functional and works properly in Western Blot, although relatively high concentrations had to be used, compared to 
antibodies used for the other Western Blot experiments. After titration a Western Blot experiment was conducted on 
cell extracts of LoVo and HeLa nuclear and mitochondrial fractions and 293T-Tet-off-hMLH1 mitochondrial extracts. 
As mentioned, bands were expected in SW480 since it is hMSH3 proficient; but not in LoVo nuclear extract.This was 
thought to give answers to whether the hMSH3 protein was present in mitochondrial fractions. These experiments were 
not successful, as nothing could be seen on the x-ray film and therefore results are not shown. Due to a lack of cell 
extracts these experiments could not be repeated. If these experiments would have been successful and showed some 
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amount of hMSH3 in mitochondrial fractions (except for LoVo mitochondrial as the cell is deficient in hMSH2 and 
therefore probably will not contain hMSH3), the next step would be the proteinase K treatment to find out whether the 
detected protein adheres to the outside of the mitochondria or if it is located inside the organelle. 
 
4.2.6 Western Blot of hPCNA 
 
Figure 9:  Ponceau Staining and Western Blot detection of hPCNA. 
Membrane was incubated with primary antibody anti-hPCNA concentration of 1:1000, and secondary antibody concentration of 1:10000 
(anti-mouse) (see Materials and methods). 
 
 
 
This experiment exhibits an uneven loading pattern in the Ponceau Staining of the membrane; however, faint bands can 
be seen in all lanes containing nuclear protein. As hPCNA is localized in the nucleus, the presence of ~34 kDa bands in 
the HeLa and LoVo nuclear fractions is expected. 
However, a sharp band in the 293T-Tet-off-hMLH1 mitochondrial lane at ~34 kDa can also be seen. This band is 
unexpected, as hPCNA is usually regarded as being localized in the nucleus. Therefore, it seems that hPCNA is either 
present within, or adhered to the outside of these mitochondria. As neither hMSH2 nor hMSH6 was found in 293T-Tet-
off-hMLH1 mitochondrial extracts, this extract does not seem to have been contaminated with nuclear proteins. 
A possible explanation to this observation could be that hMLH1 and hPCNA interact with each other in the process of 
MMR (see MMR overview on page x). It can therefore be speculated that hPCNA is transported along with the 
excessive amounts of hMLH1 into the mitochondria. Alternatively they may be actively or passively transported to the 
outside of the mitochondria. Here they might engage in noncovalent interactions with integral membrane proteins or 
proteins localized in the outer membrane. Such interactions could explain why the proteins could not be separated from 
the mitochondria in the different steps of ultracentrifugation when making the extracts. 
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4.3 Proteinase K assay  
 
4.3.1 Experimental strategy 
 
 
The proteinase K experiment was carried out in order to further investigate the findings of hMLH1 in the mitochondria 
of HCT116 + chr.3 and hPCNA in mitochondrial fractions of SW480, as shown by Houg et al. (2004). The finding of 
these proteins in mitochondria was unexpected, and has given rise to speculation whether the proteins are actually 
inside the mitochondria (which is necessary if they should participate in mtDNA repair), or adhering to the outer surface 
of the mitochondria, where they may serve a function, perhaps in modulating an apoptotic response. If on the outside, 
however, MMR proteins may merely represent a cytosolic contamination, which binds unspecifically to the 
mitochondrial envelope, thus producing a false band in the corresponding Western Blot. To examine this, an experiment 
has been designed, where in the mitochondria is incubated with proteinase K before proceeding with a Western Blot. If 
the mitochondria are adhering to the outside of the mitochondria, proteinase K will digest it, and therefore no band (of 
the specific protein) will be visible on a Western Blot of the extract. If the protein is located inside the mitochondria, 
proteinase K treatment will not digest the protein, as the mitochondrial membrane is intact at the time of proteinase 
treatment. As a positive control of the efficiency of the proteinase K, a sonication step was carried out (see figure 10). 
 
 
Figure 10: Schematic view of the Proteinase K experiment. Details are given in the text. 
 
 
If the protein is located inside the mitochondria and the mitochondrial membrane is not ruptured due to sonication the 
mitochondrion as well as the protein will stay intact. During the blotting process, the mitochondrial membrane will be 
ruptured, thus allowing for separation of the various proteins inside the mitochondria. Therefore on an SDS gel a band 
should be discovered (A1). When only proteinase K treatment is carried out, proteins on the inside of the mitochondria 
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are not digested and will show up on a gel (A2) whereas proteins situated on the outside will be digested. Sonication 
without additional Proteinase K treatment will only lead to rupture of the mitochondrial membrane and not to protein 
degradation; in this case bands will be visible in both cases, with the protein located inside or outside mitochondria (B1). 
Independent on localization of the protein no bands can be obtained if sonication and Proteinase K treatment are 
accomplished (B2). If the protein is a transmembrane protein it may, however be inaccessible to the proteinase K 
digestion even after sonication.  In that case a band is expected i B2. 
This experiment was designed to examine whether hMLH1 and hPCNA are found inside mitochondria, outside 
mitochondria, or associated with the mitochondrial envelope. Sonicated and non-sonicated hMLH1 containing 
mitochondrial extract of the cell line HCT116 + chr. 3 have been treated with proteinase K or according to figure xx.  
Similarly, the PCNA containing SW480 mitochondrial extract was used to show the localization of PCNA.   
 
4.3.2 Proteinase K results 
 
 
 
Figure 11: Western Blot obtained from the Protease K treatment showing hMLH1. 
Membrane was incubated with primary antibody anti-hMLH1 concentration of 1:500, and secondary antibody concentration of 1:10000 
(anti-mouse) (see Materials and methods). 
 
As signals could be discovered in all lanes loaded on the gel this result appears odd. Confounding enough, bands can 
also be seen in the blanks, which are supposed to contain no protein at all. Moreover the observed bands can be found at 
a size of approximately ~120 kDa and do not contain the correct size of hMLH1 (87 kDa) which also indicates that 
something went wrong in this experiment. Bands at ~87 kDa were expected in A1, A2 and B1 if the protein is located 
inside the mitochondria; and in A1 and B1 if the protein is adhering to the outside of the mitochondria. Finally, bands 
would be expected in A1, A2, B1 and B2 if hMLH1 is an integral protein in the mitochondrial membrane. A similar 
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experiment designed to establish the localization of hPCNA in SW480 mitochondria likewise failed (data not shown). 
Unfortunately, neither time nor our supply of mitochondrial extracts allowed for repetition of these experiments. 
 
 
 
4.4 Erythromycin Resistance Assay 
 
 
4.4.1 Experimental strategy 
 
 
In the attempt to investigate if the MMR proteins Msh2 and Mlh1 are involved in mitochondrial repair after oxidative 
damage, the budding yeast, S. cerevisiaehas been chosen as a model organism. S. cerevisae is commonly used as a 
model system for mammalian cells because biological mechanisms in S. cerevisiae in many cases have shown to be 
analogous to those in mammalian cells (Tugendreich et al., 1994; Rasmussen et al., 2003). For example the DNA repair 
systems in yeasts and humans seem to be highly conserved (Singh et al., 2001). Among the genes in the nDNA from S. 
cerevisiae resembling human genes the most are the central MutS homologue Msh2 and the central MutL homologue 
Mlh1(Botstein et al., 1997). In this study strains with deficiencies in the Msh2- and Mlh1 genes are used to determine 
the number of mutations in mtDNA when these proteins are not present to exert a possible repair. If Msh2 and Mlh1 are 
involved in the repair of oxidative damage in mitochondria an increased number of mutated cells will be expected in 
these strains. A yeast strain deficient in the Ogg1 protein, which is involved in the repair of oxidative damage through 
the BER pathway, in nDNA as well as in mtDNA, is used as a positive control. A colony colour assay conducted by 
Singh et al. (2001), which measures random mutations in the entire mitochondrial genome, showed that S. cerevisiae, 
containing an inactivated Ogg1 gene, produced a two-fold increase in the number of spontaneous mitochondrial 
mutations with respect to wild type yeast. It should be noted though, that the assay used in this experiment do not 
measure mutations in the entire mitochondrial genome but only specific point mutations in the genes encoding the large 
ribosomal RNA (Cui and Mason, 1989) in the mitochondria, why the mutation frequency in the present experiment 
might not reach this level. To select for yeast cells containing specific point mutations in the gene encoding 21S 
erythromycin is used. That the Ogg1 deficient strain in this study might not reach a two fold increase in the number of 
mutations is also supported by the fact that an erythromycin assay conducted by Singh et al. (2001) showed no 
significant difference between the numbers of wild type mitochondrial mutants compared to mitochondrial Ogg1 
deficient mutants. Because the cells in the present study are exposed to oxidative stress it is presumed that the number 
of mutations in wild type cells and Ogg1 deficient cells at least will be distinguishable.  
The antibiotic erythromycin has frequently been used to measure the mutation frequency in yeast cells. Normally 
mitochondrial translation is inhibited by erythromycin. However, when specific mutations in the genes coding for 
mitochondrial rRNA occur erythromycin can no longer exert its effect, thus resulting in the cells being resistant to 
erythromycin(Cui and Mason, 1989). More specifically the sites of mutations conferring resistance to erythromycin are 
located within two ribosomal loci called rib2 and rib3 at the gene encoding the 21S rRNA. In the rib 2 locus resistance 
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to erythromycin occurs when a cytosine residue at the 3993 position is replaced with a guanine residue on the non-
coding strand resulting in a CG → GC transversion. In the rib 3 locus resistance occurs when an adenine residue at the 
1951 position is replaced with a guanine residue resulting in an AU → UA transversion(Sor and Fukuhara, 1984).  
      
 
Figure 12: Model depicting the folded structure of the mitochondrial 21S rRNA comprising a peptidyl transferase loop in the ribosome unit. 
Within 21S rRNA the mutation sites conferring to erythromycin resistance is localised in the rib2 and rib3 loci. The picture of 21S rRNA also 
depicts several sites conferring resistance to the antibiotic chloramphenicol in different organisms. T is read U in RNA(Sor and Fukuhara, 
1984).  
 
Oxidative damage is introduced to the cells by addition of the redox-cycling compound menadione (2-methyl-1,4-
naphthoquinone). As its chemical name implies menadione is a quinonoid compound. It can be reduced to the 
compound semiquinone which in turn is able to generate superoxide by the reduction of molecular oxygen, thereby 
regenerating the oxidized quinone. Superoxide can subsequently be metabolized to hydrogenperoxide which in turn, 
together with Fe2+, can produce the highly reactive hydroxyl radical (Capiscol et al., 2000). A dosis-respons experiment 
showed that treatment with 2mM menadione for one hour was sufficient to introduce oxidative damage to nDNA 
without killing the cells (Machado, pers. comm.).   
 
Because cells harbour several mitochondria which each may contain several mitochondrial genomes it is not possible to 
calculate mutation frequencies as normally done in the nucleus. If resistance to erythromycin occur in only one or a few 
mitochondrial genomes, this might not be sufficient to meet the mitochondrial demand for ribosomal translation 
machinery which, in the non-mutated genomes, is knocked out when treated with erythromycin. The number of mutated 
genomes necessary to preserve the mitochondrial translation machinery under erythromycin treatment is at present not 
known. Presumably, an overweight of mutated genomes will encode sufficient ribosomes for the translation of the 
necessary mitochondrial proteins. Likewise it is not known how many mitochondria with an overweight of mutated 
genomes that are necessary to meet the energy demand of the concerned cell exposed to erythromycin. This complicates 
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the things because when cells are treated with erythromycin and not enough mitochondria are maintained in the cell, 
because it does not contain enough mutated genomes, it will either die or grow that slowly that it might not be detected 
at the erythromycin plates within the interval decided for counting. The assay might therefore not detect all mutations. 
In addition, the division of mitochondria does not follow the cell cycle which is normally taken into account when 
nuclear mutation frequency is calculated. Therefore a mutation frequency, based on calculations meant for resistance in 
the nucleus, can not be used and the number of mutated cells is therefore not presented as a frequency but as the number 
of erythromycin resistant cells per 108 cells. 
4.4.2 Results from erythromycin resistance assay 
In this section results obtained in the erythromycin assay are presented. The aim of the assay was to investigate whether 
the MMR proteins Mlh1 and Msh2 in the yeast S. cerevisae are involved in mitochondrial repair of oxidative damage. 
Because the number of erythromycin resistant colonies within each strain showed to be very scattered a table showing 
the values obtained in each assay is depicted.  
 
 
Assay Replicate WT Mlh1-/- Msh2-/- Ogg1-/- 
a 5,688 - 4,828 - 
b 2,406 - 1,000 - 
1 
c 2,727  0,840 - 
a 0,534 0,196 10,429 8,269 
b 1,515 0,930 11,333 4,375 
2 
c 11,925 5,481 6,744 16,727 
a 5,378 - 11,846 0,580 
b 4,906 13,061 0,860 3,540 
3 
c 0,006 0 6,066 7,302 
 
Table 2: The number of erythromycin resistant colonies per 108 cells in wild type, Mlh1-, Msh2- and Ogg1 deficient strains respectively. Data 
originates from three conducted assays with three replicates in each. Boxes containing no values are due to exaggerated growth of cells on 
YPD plates making counting of the number of viable colonies impossible without obtaining a great source of error. The marked values are 
considered non valid for the reasons explained in the text.     
 
In table 2 it can be seen that the number of erythromycin resistant colonies within each strain are very varied. This can 
be due to several factors. Firstly dilution errors might explain some of the variation. Likely, the very small value of 
sample c in the wild type strain of assay 3 is due to a dilution error. Approximately a factor of thousand is present 
between sample c and the two other samples in the same assay and therefore this value is excluded. Likewise sample b 
in the Msh2 deficient strain of assay 3 and sample a in the Ogg1 deficient strain of the same assay are considered as 
dilution errors with a factor ten of difference why those values are also excluded. Another reason that might explain 
some of the variance in the data is the fact that cells could be naturally mutated before treatment with menadione. Such 
jackpots would give large numbers of erythromycin resistant cells in those samples because they have had a longer 
period of time to divide. Sample c in the wild type from assay 2 is very high in comparison to the other values in this 
assay probably due to a jackpot, why this sample is sorted out. The high value of sample c in assay 2 of the Ogg1 
deficient strain might also be due to a jackpot, but it will not be proper to exclude this value because the variation of the 
values in the assay of concern makes it impossible to decide which values should excluded. The following figure is 
based on an average of the remaining, non-marked values depicted in table 2.              
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Figure 13 Average number of  erythromycin resistant colonies per 108 cells in wild type, Mlh1-, Msh2- and Ogg1 deficient strains (+SD).   
 
In table 3 it can be seen that the number of erythromycin resistant colonies of the Ogg1 deficient strain is a little more 
than doubled with respect to the number of erythromycin resistant colonies present in wild type. The number of 
mutations conferring resistance to erythromycin in the Msh2 deficient strain exceeds the number of erythromycin 
resistant cells in the wild type with approximately a doubling while the number of erythromycin resistant colonies in the 
Mlh1 deficient strain lies at approximately the same level as the for wild type. If the standard deviations are taken into 
account however, no significant differences in the number of erythromycin resistant colonies seem to exist between any 
of the strains.   
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5 Discussion 
 
5.1.1 Discussion of Western Blot and Proteinase K assay 
 
Experimental results  
 
In this section the presence and function of MMR in human mitochondria are evaluated. A possible connection between 
hMLH1 and apoptosis is suggested. Furthermore, a connection between the transport of hMLH1 and hPCNA into the 
mitochondria is proposed. Finally ideas to further experiments are suggested. In the following table results obtained in 
the present study are presented.  
 
Cell line/protein hMSH2 hMSH6 hMSH3 hPCNA hPMS2 hMLH1 
LoVo Nuclear   + +  + 
LoVo Mitochondria       
HeLa Nuclear + +  + + + 
HeLa Mitochondria      (+) 
HCT116 + chr. 3 
mitochondria 
      
SW480 
Mitochondria 
      
293Tet-off 
Mitochondria 
   +  + 
Table 3: Summary of the results obtained by Western Blot analysis.  + denotes that a given MMR protein had been detected In the 
corresponding extract. 
 
In the present study no hMLH1 was found in the mitochondrial extract of LoVo. This however, does not correlate with 
the result obtained by Houg et al. (2004) who detected hMLH1 in the mitochondrial extracts of LoVo. Unequal loading 
of the gel can not explain this absence since the Ponceau Staining showed plenty of protein. However, it could be 
possible that the hMLH1 protein present in the mitochondrial extract of LoVo found by Houg et al. (2004) is due to a 
contamination of the mitochondrial extract with nuclear proteins.  
In the mitochondrial extract of HeLa an extremely faint expression of hMLH1 was found while Rasmussen (2004) did 
not detect any hMLH1 protein in the mitochondrial extracts of this cell line (unpublished). The reason why a faint band 
is visible remains unknown. However further research concerning the presence of hMLH1 in the mitochondria of this 
human cell line is still needed. If hMLH1 is found in the mitochondria of the HeLa cell line, additional experiments 
with proteinase K could be conducted.    
In the mitochondrial extracts of LoVo Houg et al. (2004) found hPMS2 to be present. This however was not the case in 
this study. The reason why hPMS2 is not seen in the mitochondrial fraction of LoVo, as would have been expected, 
could be caused by improper vortexing of the samples before loading on the SDS gel. As mitochondria sediments very 
quickly, when in suspension, this may have decreased the amount of protein transferred to the samples. This might 
explain the lack of hPMS2 in the present experiment.  
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Houg et al. (2004) detected PCNA in the mitochondrial extracts of LoVo while unpublished results by Rasmussen have 
shown hPCNA to be present in the mitochondrial extract of HeLa. The results obtained in those studies do not 
collaborate with the result obtained in this study since no expression of hPCNA was found in either LoVo or HeLa 
mitochondrial extracts. The lack of hPCNA in those samples could be explained by unequal loading of the SDS gel. 
Hardly any protein is visible in the HeLa and LoVo mitochondrial lanes on the Ponceau Staining so this might be a 
plausible explanation. It cannot be ruled out however, that the mitochondrial extracts used by Houg et al. (2004) and 
Rasmussen were contaminated. Thus the presence of hPCNA in the mitochondrial fractions of LoVo and HeLa is still 
uncertain. The experiments conducted could be improved by using nuclear extracts from the 293T-Tet-off-hMLH1 cell 
line. Western Blots including this cell extract would provide a comparison between hMLH1 levels in the nucleus and 
mitochondria and thereby give a clue as to whether its appearance in mitochondrial extracts might be due to nuclear 
contamination. For nuclear import comparable amounts of other proteins, such as hPMS2 are needed. If these proteins 
are not present in equal amounts, the probability that excess hMLH1 can be found in the cytosol rises, and may then 
adhere to the outside, or be transported into the mitochondria. 
Another improvement could be accomplished by using cell extract from freshly harvested cells, to evict any degradative 
influence of repeated freezing and thawing of the extracts. Furthermore the amount of protein contained in each extract 
should be examined by Bradford assays. As the extracts have been used several times before, maybe lack of proper 
vortexing before pipetting, has caused the extracts to deviate from the original protein concentrations. 
As the experiment investigating the presence of hMSH3 in human mitochondria failed, further experiments are needed 
to obtain this data. The attempts to investigate whether the previous findings of hMLH1 and hPCNA in mitochondria is 
due to the protein adhering to the outside of mitochondria also failed to produce any results. As the Ponceau Staining 
from the proteinase K treatment indicates, the gel was loaded very unequally. Here, conducting a Bradford assay with 
the remaining extract could be a possibility to reveal whether the concentrations in the extract is lower than expected, 
thus resulting in lower amounts being loaded. However, increasing the amount of protein for this experiment seems 
necessary to obtain valid results. If the results obtained indicated that either hMLH1 or hPCNA seem to act as 
transmembrane proteins in the mitochondrial membrane, another experiment using Triton X instead of sonication could 
be designed. The advantage of Triton X application is that in contrast to sonication it does not produce smaller 
fragments of membrane, but completely destroys it. Of course the new experimental setup would require several 
positive and negative controls to rule out the presence of the protein of interest inside or outside the organelle.   
In the present study hMLH1 was found in the 293Tet-off mitochondrial extract. Unfortunately nuclear extract was not 
available making it impossible to compare the expression of hMLH1 in mitochondrial and nuclear extract respectively. 
The presence of hMLH1 in the mitochondrial extract of the 293Tet-off cell line could be explained by hMLH1 adhering 
to the outer mitochondrial membrane, because a general over-expression of hMLH1 would lead to an increased amount 
of hMLH1 in the cytosol since hMLH1 is translated here. Transport of hMLH1 to the nucleus has been shown to be 
more efficient when dimerised with its partner hPMS2. When hMLH1 and hPMS2 forms a complex, a conformational 
change occur, which uncover the NLS which is required for transport to the nucleus (Wu et al., 2003). If hPMS2 is not 
expressed at the same level as hMLH1 a surplus of hMLH1 will exist in the cytosol and a fraction of hMLH1 will 
remain in the cytosol. This could lead to an increased risk of hMLH1 adhering to the outer mitochondrial membrane by 
either specific or unspecific interaction with proteins embedded in the mitochondrial membrane. Since hPCNA is also 
expressed in the 293T-Tet-off-hMLH1 cell line surplus hMLH1 may complex with hPCNA leading to a conformational 
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change which might uncover a MTS. A search for a mitochondrial targeting sequence in hMLH1 using the program 
MITOPROT revealed a high probability that hMLH1 contains such a sequence. Even though hMLH1 might contain an 
MTS, exposure of the targeting signal is required for effect; and can happen when protein-protein interactions occur. 
The fact that hMLH1 and hPCNA has been shown to interact (Paunesku et al., 2001), and that hMLH1 might contain a 
MTS could indicate that these two proteins are transported to the mitochondria as a complex. However the hPCNA 
found in the mitochondria of the 293T-Tet-off-hMLH1 cell line might not be related to MMR, since hPCNA is also 
involved in BER system, and recombination, which are both found in mitochondria (Maga & Hübscher 2003) 
No cell lines used in the experiment showed signs of being apoptotic since the hMLH1 protein in the nuclear extracts 
did not show a degradation pattern like the one reported by Houg et al. (2004). To elucidate the role of hMLH1 in 
apoptosis an experiment could be conducted where cells were treated with different concentrations of alkylating agents 
or other apoptosis inducing agents as for example TRAIL and etoposide. After exposure to these agents a purification of 
nuclear and mitochondrial extracts, and subsequent Western Blotting could be carried out. A comparison of treated and 
non-treated cells would perhaps give an indication of whether a connection between the degree of apoptosis and 
mitochondrial localization of hMLH1 exist. Furthermore, Western Blots testing for antibodies against the pro-apoptotic 
protein Bax and the anti-apoptotic protein Bcl-2 could be performed to investigate the putative connection between the 
localization of these proteins and hMLH1. In addition it could be interesting to use an antibody against caspase-3 to test 
how the localization of the MMR proteins correlates with the localization and activation of this protein. The new 
Western Blot experiments suggested could be visualized using a different technique. Secondary antibodies containing 
fluorescence properties would allow quantification of proteins and thereby drawing conclusions about their importance 
during apoptosis. 
PCNA is involved in many pathways in the cell, for example DNA replication, DNA repair, cell cycle control and 
apoptosis, and some of these pathways may act in the mitochondria, e.g. apoptosis.  
A potential role for PCNA in mitochondria could be that it interacts with the human DNA polymerase γ, known as the 
mtDNA polymerase, which functions in replication and repair of mtDNA (Longley et al., 2001).  
Paunesku et al. (2001) found that mtDNA polymerase γ contains a putative PCNA binding sequence, as well as a 
binding sequence for the apoptotic protein Bcl-x, which could be found through a BLAST analysis (see the apoptosis 
section). A recent article by Maga & Hübscher (2003) lists a number of PCNA interaction partners, but polymerase γ 
was not among those listed. An explanation for this could be that they did not find the DNA polymerase γ to interact 
with PCNA, or simply that there is no any experimental data substantiating this, besides the BLAST analyse conducted 
by Paunesku et al. (2001).    
Findings of PCNA interaction with the MMR proteins hMSH2 and hMLH1, in both yeast and human cells, indicate that 
hPCNA possesses a central role in the MMR process (Umar et al., 1996). Another possible role of PCNA in 
mitochondria could be that it mediates activation of apoptosis. It is known that during cell cycle arrest, PCNA interacts 
and forms complexes with several p53 regulated proteins. Gadd45, which is a growth arrest and DNA-damage-
inducible protein, plays an important role in regulation of cell growth, and can serve as an apoptotic factor (Paunesku et 
al., 2001; Vairapandi et al., 2000). Gadd45 mutants were shown to lack the PCNA interaction domain, and were found 
to induce apoptosis, because of the lack of interaction between Gadd45 and PCNA, which triggers a negative growth 
control (Vairapandi et al., 2000; Maga & Hübscher, 2003). 
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Future experiments 
 
Interaction studies 
The results obtained by Western Blot experiments could be supported by conducting Yeast-two-Hybrid screens, in 
which hMLH1 could be tested for interaction with several putative mitochondrial interaction partners. Since successful 
expression requires both a DNA binding domain and an activation domain, which do not necessarily have to be located 
on the same protein, this technique takes advantage of that fact. Screens using the Yeast-two-Hybrid technique are 
achieved by constructing a vector expressing the protein of interest or the bait protein, in this case hMLH1, linked to a 
binding domain which is supposed to bind to the promoter region of a certain easily detectable reporter protein. The 
potential binding partner, also called prey or hunter protein, is cloned into another vector adjacent to an activator 
domain serving for the activation of the same promoter. Both vectors need to be transfected into the yeast cells for 
example via sonication or chemical rupture. When both proteins interact with each other the DNA binding domain and 
the activation domain will form a functional transcriptional activator, the reporter gene sequence will be transcribed and 
translated into protein, which is then measureable (Phizicky & Fields, 1995; van Criekinge & Beyaert, 1999). 
Another approach which seems to be easier to carry out is a Co-immunoprecipitation assay. In this experiment hMLH1 
antibodies could be supplied to a mitochondrial extract and form an immune complex together. A matrix, e.g. 
sepharose, is used to capture the antibody and the antigene bound to it. At the same time, proteins interacting with the 
protein coupled to its antibody will also be immobilized and can be detected by applying the appropriate antibody 
carrying an enzyme label allowing detection. For the purpose of distinguishing whether hPCNA is a putative interaction 
partner or not this experiment appears more promising as no yeast specific proteins might interfere with the results. A 
bigger problem carrying out these experiments rather seems to be that huge amounts of mitochondrial extract are 
required to follow this strategy. Pilot experiments should be conducted, aiming to verify that the antibody for the bait 
protein (hMLH1) recognizes different epitopes than does the one which is supposed to bind to the putative prey protein 
(hPCNA) (Paunesku et al., 2001). Likewise it should be kept in mind that Co-immunoprecipitation experiments are not 
conducted in vivo, therefore the biological relevance of found interacting proteins should be regarded critically. Another 
critical point is that indirect interactions cannot be detected, e.g. binding of a third protein between bait and considered 
prey protein, as only the binding of target protein by its antibody is detected. 
 
Localization experiments using fluorescencent dyes 
 
Localization experiments using fluorescence labelled (e.g. GFP) hMLH1 protein could give a clue about its role in 
apoptosis by determining its localization. Therefore a vector strongly expressing the labelled protein should be created 
and transfected into a cell culture. Exposure to increasing concentrations of DNA-damaging agents such as TRAIL or 
etoposide could be applied and after an appropriate time of incubation be viewed with a fluorescence microscope. This 
could present evidence, as to whether hMLH1 really is present in mitochondria or if it is an artefact caused by nuclear 
or cytoplasmic contamination. One approach for localization experiments could be the introduction of mutations in the 
NLS which is expected to evict transport of the protein to its destination. Maybe, if this localization site is defective the 
protein will be transported to another destination instead. This idea is supported by an investigation using the computer 
program MITOPROT which calculated a probability of hMLH1 containing a MTS of 0.91, which makes it rather likely 
that hMLH1 contains a MTS. A protein known for its presence in the nucleus only, BRDII, a nuclear-specific protein, 
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was used as a negative control in the same program, resulting in a probability of 0.04 for containing a mitochondrial 
signalling sequence. To state these results, mutation of the concluded MTS could be another tool, to verify the 
hypothesis. A mutated MTS should prevent transport of the protein into mitochondria then. A fluorescent dye, such as 
MITOTRACKER, could help to pinpoint the mitochondrial membrane and thereby facilitate discovery of the labelled 
hMLH1 and putative interactions of the protein with the mitochondrial membrane or its (adjacent proteins). 
Additionally possible interaction partners like hPCNA could be labelled with another fluorescence emitting protein, e.g. 
Yellow luorescent protein. Using this technique, it would be possible to see where a certain protein of interest is located 
during apoptosis and whether co-localization appears. 
 
5.1.2 Discussion of erythromycin assay 
 
In the present study there are no indications implying that Msh2 or Mlh1 could be involved in the correction of 
oxidative damage introduced by menadione, at least not when the standard deviations are taken into account. If Msh2 
and Mlh1 do not correct oxidative damage in mtDNA, mitochondria might not harbour a MMR system similar to the 
one in the nucleus. However more data is needed to conclude that this is really the case. As mentioned in the 
experimental strategies for the erythromycin assay presumably does not detect all mutated cells, because a certain 
number of mitochondrial genomes probably have to be mutated before they are able to encode translation machinery 
sufficient enough to carry out the production of mitochondrial proteins, preserving mitochondria, necessary to the cells 
energy production. Thus the number of mutated cells detected in this assay might be a low estimate of the actual 
number of mutational events.   
 
The actual conduction of the assay is important when the reliance of data is evaluated. After treatment with menadione, 
some of the culture was transferred to a dilution series to estimate the number of viable cells while some of the culture 
was spinned down, washed and plated onto erythromycin plates to estimate the number of mutated cells. For every 
replicate an amount of culture was first transferred from the stock culture to the starting vial in the dilution series 
immediately diluting the menadione concentration. Next an amount of the same stock culture was transferred to vials 
meant for plating on erythromycin plates. The cells in those vials were spun down and finally washed thoroughly with 
water. At least half an hour went before all twelve replicates had been through this procedure and been washed properly 
resulting in 30 minutes additional exposure to menadione for the last treated cultures. This could lead to fewer mutated 
cells if the extra treatment with menadione leads to oxidative damage in a degree resulting in cell death. However 
conduction of an experiment with different exposure times to menadione would solve whether or not this is the case. A 
solution to bypass this uneven exposal to menadione which arises when only one person is conducting an assay could be 
to include the half hour of handling time before the washing step in the one hour of menadione treatment. This would 
minimize the extra exposure to menadione. However the cultures do not always grow evenly to log phase, where the 
treatment with menadione should start, complicating this proposal.  
As previously mentioned in the result section another source of error is the presence of jackpots, being already 
mutated cells which, because of their time advantage, have had the time to divide for a longer time period than the cells 
which have been mutated and thereby have become resistant to erythromycin due to the induction of oxidative damage. 
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Jackpots therefore lead to samples with an increased number of resistant cells. Occurrence of naturally resistant cells 
can not be avoided but the likelihood can be reduced by always inoculating new individual colonies in each assay.        
Another explanation for the lack of significant differences between the wild type and the MMR mutated strains could be 
that the erythromycin assay is very specific in contrast to for example the colony colour assay which measures random 
mutations in the entire mitochondrial genome. As mentioned before only specific point mutations in the loci encoding 
the large ribosomal RNA (Cui and Mason, 1989) confer resistance to erythromycin. Conduction of a colony colour 
assay might give an increased effect and a more precise difference between the numbers of mutated cells. Conduction of 
a colony colour assay with the same strains could therefore be interesting. In the colony colour assay a yeast strain 
mutated in the gene Ade2, which is involved in biosynthesis of adenine, is used. This strain accumulates red pigment 
and therefore appears red. If a mitochondrial dysfunction arises the cells will turn white. To investigate whether this 
dysfunction is due to mutations in nuclear genes or mitochondrial genes encoding mitochondrial proteins this strain 
must be crossed with a Rho0 cell which is devoid of mtDNA. If the mitochondrial dysfunction is due to a mutation in 
mtDNA the Rho0 cells will not be able to complement the mutation, resulting in the colonies remaining white. If the 
mitochondrial mutation on the other hand is due to a mutation in nDNA the dysfunction can be complemented by the 
Rho0 strain, which contains a functional nuclear genome, resulting in the cells turning red (Kim et al., 2002). If this 
experiment was to be carried out, crosses of a strain mutated in Ade2 and strains deficient in Msh2 and Mlh1 
respectively are necessary to get a strain with both characteristics. This, however, requires that the strains including the 
subsequently used Rho0 cells should have different mating types. Characteristics of both Ade2 deficiency and 
Msh2/Mlh1 deficiency could also be obtained by mutagenesis. Conduction of a colony colour assay is therefore not that 
simple.  
Perhaps the lack of significant differences between the number of erythromycin resistant cells in Ogg1-, Mlh1-, and 
Msh2 deficient strains could also be due to overlapping substrates for the Ogg1 protein and the MMR proteins. This 
could be true since a functional overlap between MMR and Ogg1 has been found in the nucleus. For example 
combinational mutations in Msh2 together with Ogg1 results in a synergistic increase in the number of nDNA mutations 
(Ni et al., 1999). In addition investigations on the Msh2-Msh6 complex, present in the nucleus, have shown that this 
complex binds specifically to 8-oxo-G:A and 8-oxo-G:C mismatches (Ni et al., 1999). However, a functional overlap 
could be investigated by constructing a double mutated strain deficient in Mlh1 or Msh2 together with Ogg1.  
If resistance to erythromycin shall occur due to the incorporation of the most abundant base lesion caused by oxidative 
damage, 8-oxo-G, a guanine residue or a cytosine residue should be present at the specific sites conferring resistance to 
erythromycin in the gene encoding 21S rRNA. Only at the rib2 loci a chance exists for the generation of 8-oxo-G since 
the specific site conferring resistance to erythromycin contains a cytosine residue, and thus a guanine residue on the 
complementary strand. The presence of only one residue able to mutate due to the generation of 8-oxo-G makes 
resistance to erythromycin less likely. In addition, if the incorporation of 8-oxo-G results in the frequently occurring 
GC→TA transition, the right mutation conferring resistance to erythromycin might not arise. An example is given in 
figure 14. 
    
Conduction of an erythromycin assay using untreated cells could give an indication of how big an effect menadione 
actually exerts on the cells. However, an erythromycin assay conducted by Singh et al. (2001) showed no significant 
difference between an Ogg1 deficient yeast strain and the wild type. The fact that 8-oxo-G can only arise at one of the 
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specific sites conferring resistance to erythromycin indicates that erythromycin might not be the most appropriate 
antibiotic for the purpose of detecting repair of oxidative damage. This is supported by the fact that the Ogg1 deficient 
strain lacking Ogg1 which are known to correct 8-oxo-G lesions do not seem to have a significant higher number of 
erythromycin resistant cells than wild type. The gene encoding 21S rRNA contains apart from the sites conferring 
resistance to erythromycin, also sites responsible for resistance to the antibiotic chloramphenicol. However 
chloramphenicol will presumably not be more useful in the selection of mutated cells than erythromycin since only one 
of the two sites conferring resistance to chloramphenicol contains a residue that can be mutated due to the generation of 
8-oxo-G (see figure 12). 
 
Figure 14: In the gene encoding 21S rRNA two specific sites confer resistance to erythromycin when mutated. Only one can be mutated due 
to generation of 8-oxo-G. This site contains a cytosine residue in the wild type rRNA while the corresponding transcribed strand of DNA 
must contain a guanine residue. When this guanine residue is oxidized 8-oxo-G arises, frequently leading to the incorporation of adenine 
when replicated. In the next round of replication adenine will be paired with thymine. Thus a cytosine residue in the rRNA is replaced by an 
adenine residue. However, according to Sor & Fukuhara (Sor and Fukuhara, 1984) resistance to erythromycin only occurs when a cytosine 
residue is replaced by a guanine residue (see figure 12). Punctured line: RNA, unbroken line: DNA. 
 
In future experiments it could be interesting to take a closer look at the specific sites conferring resistance to 
erythromycin and investigate which kind of nucleotide substitutions that are seen in mtDNA and if they can actually be 
caused by oxidative damage. To find out which nucleotide substitutions that render cells resistant to erythromycin a 
PCR reaction could be carried out using primers recognizing sequences on either site of the rib2 or rib3 loci positioned 
in the mtDNA originating from an erythromycin resistant strain and a wild type strain respectively. After the PCR 
reaction, sequencing of the PCR product should be carried out and the nucleotides positioned at the specific sites 
conferring resistance to erythromycin should be compared between the wild type and the mutant strain. This will 
elucidate the nucleotide substitutions of concern. At the same time the nucleotide tops will elucidate whether the 
erythromycin resistant colony consist of homoplasmic or heteroplasmic cells. If the erythromycin resistant colony 
contains homoplasmic cells, one distinct nucleotide top will appear when the sequencing program CHROMAS is used. 
If the erythromycin resistant colony contain heteroplasmic cells both wild type nucleotide tops and mutated nucleotide 
tops will be seen at the same nucleotide position. If the last scenario is the case, showing that the mitochondria of the 
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erythomcin resistant strain contains two kinds of DNA, the mentioned method however will not give an actual 
relationship between the number of wild type- and mutated genomes respectively. This could, however be elucidated if 
mtDNA was purified from an erythromycin resistant colony and afterwards cut with restriction enzymes to get access to 
the enclosed genomes. In addition the genomes should be cloned and afterwards randomly picked clones could be 
sequenced to get the relationship between the number of wildtype- and mutated genomes. The frequency of cloned wild 
type- and mutational genomes respectively is estimated to reflect their relationship in the mitochondria since no 
difference between their preferences for restriction enzymes, their ability to be ligated or transfected into E. coli should 
exist.  
 
Conclusion 
The present study showed presence of hMLH1 and PCNA in 293Tet-off-hMLH1 mitochondrial extracts and thereby 
supported previous studies (Houg et al., 2004), but their localization in- or outside the organelle remains to be 
elucidated. However, presence of hMSH3 in mitochondria is another question, which has not been solved, yet. Our 
studies suggest that the existence of common MMR in mitochondria is unlikely, as our investigations showed absence 
of hMSH2 and hMSH6 in mitochondria. Further investigations are required to confirm the above mentioned results. 
Even though the proteinase K treatment has failed to produce any results regarding the putative adherence of hMLH1 
and hPCNA to the mitochondrial membrane, this remains an interesting line of inquiry. A role for Msh2 and Mlh1 in 
the repair of oxidative damage in the mitochondria of S. Cerevisiae could not be confirmed.  
More data is needed to clarify this result. 
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7 Appendix 
 
7.1.1 hMLH1 Verification 
 
Figure 15: Ponceau Staining and Western Blot of hMLH1 activity  
 
In this experiment, two lanes were tested with hMLH1 antibody, as we had experienced difficulties with this antibody 
in previous experiments, and needed to verify that the hMLH1 antibody was functional. To find out whether failure to 
obtain results from the protease K treatment was caused by the hMLH1 antibody being degraded, a test was carried out 
to determine whether the antibody was still working.  
Concentrations of 1:250 (primary antibody) and 1:5000 (secondary antibody) were used. As fig. 15 implies very intense 
bands are obtained in both lanes, containing LoVo and SW 480 nuclear, at the appropriate size of 87kDa. Sharp and 
intense bands at sizes of 60, 45 and 27 kDa can be attributed to unspecific binding with other proteins containing similar 
epitopes or to degradation products of hMLH1.  
 
 
 
 
